A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: testing (1000), conducting tests (149)

Immunotherapy - patient information

Description
This factsheet explains what immunotherapy is, how it works and what the possible side effects are.
Url
/Media/UHS-website-2019/Patientinformation/Cancercare/Immunotherapy-2698-PIL.pdf

Vismodegib

Description
Chemotherapy Protocol BASAL CELL CARCINOMA (BCC) VISMODEGIB Regimen  BCC - Vismodegib Indication  The patient either has; a. Gorlin Syndrome with non-locally
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Vismodegib.pdf

Rucaparib

Description
A document based on Rucarib, an ovarian cancer condition.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Rucaparib.pdf

Sotorasib

Description
A Chemotherapy Protocol for Sotorasib, associated with Lung Cancer.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Sotorasib.pdf

Carfilzomib(14 day)-Dexamethasone(20) Ver1

Description
Chemotherapy Protocol MYELOMA Carfilzomib (14 day)-Dexamethasone (20) Regimen  Myeloma – Carfilzomib-Dexamethasone (20) Indication  Carfilzomib in combination with dexamethasone is an
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/carfilzomib14-day-dexamethasone20-ver1.pdf

MyelomaBortezomib IV DexamethasonePabinostatThalidomide 21day Ver1.1

Description
Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (IV)-DEXAMETHASONE-PANOBINOSTAT-THALIDOMIDE Regimen (21 day) • Multiple Myeloma – Bortezomib (IV)-Dexamethasone-Panobinostat-Thalidomide (21 day
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-IV-DexamethasonePabinostatThalidomide-21day-Ver1.1.pdf

Docetaxel-Nintedanib v1

Description
Chemotherapy Protocol NSCLC CANCER DOCETAXEL-NINTEDANIB Regimen NSCLC – Docetaxel-Nintedanib Indication Advanced or metastatic NSCLC of adenocarcinoma origin that has progressed
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Docetaxel-Nintedanib-v1.pdf

Ceritinib 450mg

Description
Ceritinib
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Ceritinib-450mg.pdf

Cisplatin Doxorubicin Methotrexate Vinblastine (accelerated) ver1.1

Description
Chemotherapy Protocol BLADDER CISPLATIN-DOXORUBICIN-METHOTREXATE-VINBLASTINE (Accelerated MVAC) Regimen Bladder-Cisplatin-Doxorubicin-Methotrexate-Vinblastine (AccMVAC) Indication First or second line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-Doxorubicin-Methotrexate-Vinblastine-accelerated-ver1.1.pdf

InP-Bleomycin-Cisplatin-Etoposide (5 day-Mod-BEP) Ver1.2

Description
Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day Modified) In-Patient Regimen Regimen Germ Cell – InP-Bleomycin-Cisplatin-Etoposide
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Bleomycin-Cisplatin-Etoposide-5-day-Mod-BEP-Ver1.2.pdf
411 to 420 of 517
Previous … 40 41 42 43 44 … Next